Status:
COMPLETED
Protocol for Admission Toxigenic C. Difficile Surveillance
Lead Sponsor:
Endeavor Health
Conditions:
Clostridium Difficile Infection
Eligibility:
All Genders
Up to 1 years
Brief Summary
Background: Clostridioides (formerly Clostridium) difficile Infection (CDI) is a persistent healthcare issue. In the US, CDI is the most common infectious cause of hospital-onset (HO) diarrhea. Objec...
Detailed Description
Background: Clostridium difficile infection (CDI) remains a constant, even increasing, clinical infection threat in the United States and Europe. New preventive strategies are urgently needed. Curren...
Eligibility Criteria
Inclusion
- Hospital admission
Exclusion
- None
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
148549 Patients enrolled
Trial Details
Trial ID
NCT04014608
Start Date
July 1 2016
End Date
December 31 2018
Last Update
September 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NorthShore University HealthSystem Research Institute
Evanston, Illinois, United States, 60201